CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment
Authors:
- Olga KuleminaOKOlga Kulemina
- Natalia LazorkoNLNatalia Lazorko
- Tamara ChitanavaTCTamara Chitanava
- Nadia SiordiaNSNadia Siordia
- Nadezhda ShnalievaNSNadezhda Shnalieva
- Elena TochenayaETElena Tochenaya
- Polina MateikovichPMPolina Mateikovich
- Elza LomaiaELElza Lomaia
Open Access
- 30 August 2023
- journal article
- abstracts
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 23, S343-S344